Tag:

HIV

Latest Headlines

Latest Headlines

Glaxo's ViiV venture adds $5B combo pill to its HIV-fighting armory

GlaxoSmithKline may be suffering from R&D setbacks, generic competition and corruption investigations in a dozen countries, but its HIV-oriented venture ViiV Healthcare is racking up new OKs. Friday, the company scored the FDA's blessing for a combo drug pegged at $5 billion in peak sales.

Viral inducers plus antibodies thwart latent HIV in mice

A new strategy that uses broadly neutralizing antibodies combined with a cocktail of viral-inducing compounds may be able to stop HIV from rebounding, according to researchers at Rockefeller University.

Medicated electrospun fabric offers alternative delivery method for HIV-preventing drugs

Researchers at the University of Washington have developed a medicated, electrospun fabric that could prevent HIV infections in women.

AbbVie decides against Supreme Court appeal for ruling that extended rights to gays

Without explaining why, AbbVie has decided not to appeal a court ruling that extended rights to gay jurors which materialized out of litigation it has been waging with GlaxoSmithKline over the pricing of an HIV med. But it is seldom a good idea for a pharma company to antagonize its patient base. And gay men make up a significant number of the patients on HIV drugs sold by the drugmaker.

SRI's in-house CRO inks a $49M deal with NIH

The CRO unit of nonprofit researcher SRI International has paired up with NIH's National Institute of Allergy and Infectious Diseases, signing a $49 million contract to handle preclinical work on potential treatments for HIV.

'Fossil' virus discovery could lead to HIV immunotherapy

A new discovery of an ancestral fossil virus buried within everyone's genomes might provide the key to eradicating HIV.

A missile, a plane crash and a profound loss to AIDS research

Unfortunately, the biggest news coming out of the 20th International AIDS Conference involves the researchers who were killed on their way there.

AIDS 2014: Norway's Bionor produces possible biomarker to predict HIV vaccine effectiveness

Norway's Bionor Pharma and U.K. scientists claim they've identified a biomarker in some patients that may be connected with an improved response to a therapeutic HIV vaccine now under development.

Vaginal ring achieves localized, sustained release of anti-HIV drugs

A novel intravaginal ring to prevent HIV showed promise in pig-tailed macaque monkeys, demonstrating the benefits of sustained and controlled topical drug delivery over oral intake. 

J&J teams with Glaxo's ViiV on an HIV combo treatment

Johnson & Johnson has signed a deal with ViiV Healthcare, the HIV-focused venture majority-owned by GlaxoSmithKline, to spin their two antivirals into a single tablet, potentially sparing patients from some harsh side effects associated with current therapies and challenging Gilead Sciences' dominance in the field.